C12Y 304/24003
Microbial collagenase
Official title: Microbial collagenase (3.4.24.3)
C12Y304/24003 (Microbial collagenase) appears on 63 US grants and 124 published applications in this corpus.
Search patents in C12Y- Granted patents
- 63
- Published applications
- 124
- Assignees
- 69
- Inventors
- 183
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 1 | 0 |
| 2012 | 0 | 3 |
| 2013 | 1 | 2 |
| 2014 | 2 | 6 |
| 2015 | 1 | 8 |
| 2016 | 1 | 8 |
| 2017 | 9 | 11 |
| 2018 | 4 | 6 |
| 2019 | 8 | 7 |
| 2020 | 4 | 5 |
| 2021 | 3 | 8 |
| 2022 | 3 | 4 |
| 2023 | 6 | 6 |
| 2024 | 6 | 13 |
| 2025 | 5 | 13 |
| 2026 | 6 | 16 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Collagenase agent and use thereof29 Sep 2026US 12,747,435 B2Amano Enzyme Inc.
- Use of clostridium histolyticum protease mixture in promoting wound healing4 Aug 2026US 12,697,374 B2Smith & Nephew, Inc.
- Process intermediate in the purification of collagenase drug substances2 Jun 2026US 12,644,108 B2Endo Operations Limited
- Blends containing proteases5 May 2026US 12,618,058 B2Roche Diagnostics Operations, Inc.
- Nanomaterials containing constrained lipids and uses thereof10 Mar 2026US 12,569,438 B2Georgia Tech Research Corporation
- Methods Of Treating Plantar Fibromatosis1 Oct 2026US 2026/0295023 A1
- Brevibacillus laterosporus and method for extracting collagen/collagen peptides using brevibacillus laterosporus10 Sep 2026US 2026/0265344 A1Barel(Guangzhou)New Material Technology Co.,Ltd
- Nanomaterials containing constrained lipids and uses thereof13 Aug 2026US 2026/0232587 A1Georgia Tech Research Corporation
- Method of producing collagenase13 Aug 2026US 2026/0234593 A1Endo Operations Limited
- Enzyme composition for producing food30 Jul 2026US 2026/0215444 A1Nagase Viita Co., Ltd.
Most cited
By later US patents
- Reduction of adipose tissue28US 7,824,673 B2Advance Biofactures Corporation · 2010
- Reduction of adipose tissue15US 6,958,150 B2Advance Biofactures of Curacao, N.V. · 2005
- Clostridium histolyticum enzymes and methods for the use thereof15US 9,757,435 B2Endo Global Ventures · 2017
- Devices and methods for reducing the appearance of cellulite12US 10,117,892 B2Allergan, Inc. · 2018
- Fusion proteins of collagen-binding domain and parathyroid hormone12US 8,450,273 B2Board of Trustees of the University of Arkansas · 2013